The University of Oxford and its partner The Ellison Institute of Technology (EIT) have secured £118m funding to launch an ambitious new programme of vaccine research.

Advancements in artificial intelligence (AI) are reshaping the landscape of modern medicine, particularly in the field of oncology. One of the most exciting developments is the acceleration of ...

In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based ...

National Institutes of Health (NIH) Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research contracts because the general public does not ...

CAMBRIDGE, Mass., August 28, 2025 – Raina Biosciences Inc., (“Raina”), an mRNA technology and therapeutics company, today announced the publication of data from its generative AI platform in Science.

Raina Biosciences Inc. (Raina), an mRNA technology and therapeutics company, has released data from its generative AI platform in Science. The data supports Raina's pioneering approach to mRNA design ...

– GEMORNA is world’s first generative AI platform purpose-built for mRNA design and optimization, demonstrating state-of-the-art performance across diverse mRNA therapeutic applications – – GEMORNA ...

Raina Biosciences published data from its generative AI platform in a study, “Deep generative models design mRNA sequences with enhanced translational capacity and stability,” recently published in ...